Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles

Figure 3

The SHP2-targeted nanoparticles binding specificity test. Representative results from in vitro experiments after exposure to SHP2-targeted and nontargeted nanoparticles. Note the specific attachment of SHP2-targeted nanoparticles and the substantial binding inhibition following the administration of nontargeted nanoparticles. Nanoparticles are shown as red dots. .